August 1, 2018
Press Release Lipogems

Does Lipogems Want Orthopedic Surgeons to Think It’s Okay With the FDA to Use Fat-derived Fuzz Balls to Treat Orthopedic Conditions Like Knee Osteoarthritis? Part Two

Physicians in the regenerative medicine community were startled to read a press release issued on July 5th  by Lipogems, which seemed to suggest that the FDA had reversed or at least modified the prohibition on using adipose tissue to treat musculoskeletal conditions the Agency just released in a Guidance on Minimal Manipulation and Homologous Use last...
Read More